due to her unfavorable financial situation. Risks Egg donor The procedures for the donor and the medication given to her are identical to the procedures and medications used in autologous IVF (i.e., IVF on patients who are using their own eggs). The egg donor thus has the same risk of complications from IVF as an autologous IVF patient would, such as bleeding from the oocyte recovery procedure and reactions to the hormones used to induce hyperovulation (producing more than one egg), including ovarian hyperstimulation syndrome (OHSS) and, rarely, liver failure. According to Jansen and Tucker, writing in the same assisted reproductive technologies textbook referenced above, the risk of OHSS varies with the clinic administering the hormones, from 6.6 to 8.4% of cycles, half of them "severe". The most severe form of OHSS is life-threatening. Recent studies have found that donors were at less risk of OHSS when the final maturation of oocytes was induced by GnRH agonist than with recombinant hCG. Both hormones were comparable in the number of mature oocytes produced and fertilization rates. A larger study in the Netherlands found 10 documented cases of deaths from IVF, with a rate of 1:10,000. "All of these patients were treated with GnRH agonists and none of these cases have been published in the scientific literature." The long-term effect of egg donation on donors has not been well studied, but because the same medications and procedures are used, it is likely similar to the long-term effects (if any) of IVF on patients using their own eggs. The evidence of increased cancer risk is equivocal; some studies have found a slightly increased risk, particularly for those with a family history of breast cancer, while other studies have found no such risk or even a slightly reduced risk in most patients. 1 in 5 women report psychological effects—which may be positive or negative—from donating their eggs, and two-thirds of egg donors were happy with the decision to donate their eggs. The same study found that 20% of women did not recall being aware of any physical risks. In accordance with the American Society for Reproductive Medicine guidelines, female donors are given a limit of 6 cycles that they may donate in order to minimize the possible health risks. Initial evidence suggests that repetitive oocyte donation cycles does not cause accelerated ovarian aging, evidenced by absence of decreased anti-Müllerian hormone (AMH) in such women.